Literature DB >> 1434115

Myocardial Na+ during ischemia and accumulation of Ca2+ after reperfusion: a study with monensin and dichlorobenzamil.

T Kawada1, Y Yoshida, H Sakurai, S Imai.   

Abstract

The intracellular cation contents were determined in isolated perfused rat heart using cobaltic EDTA as a marker of the extracellular space. In hearts in which Na+ accumulation was induced with monensin, a Na+ ionophore, during 20 min-ischemia which otherwise did not result in accumulation of Na+, the levels of Na+ and Ca2+ were significantly higher after reperfusion with a significant decrease in K+. While the recovery of the cardiac mechanical function (CMF) was complete after reperfusion in control hearts, the recovery was incomplete in monensin-hearts. Dichlorobenzamil (DCB), the most specific inhibitor of Na(+)-Ca2+ exchanger, infused for 10 min before induction of ischemia in a dose of 10(-5) M, which produced a definite suppression of CMF (over 80%), inhibited the accumulation of Ca2+ and Na+ and the loss of K+ and ATP after 40 min-ischemia and reperfusion. The same dose of DCB given for 3 min before induction of ischemia and after reperfusion, which produced a less than 20% inhibition of CMF, failed to prevent the Ca2+ accumulation after 40 min-ischemia and reperfusion. These findings are at variance with the idea that the accumulation of Na+ during ischemia and the consequent augmented operation of Na(+)-Ca2+ exchange is responsible for accumulation of Ca2+ after reperfusion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434115     DOI: 10.1254/jjp.59.191

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  2 in total

1.  Ischemic changes in myocardial ionic contents of the isolated perfused rat hearts as studied by NMR.

Authors:  T Ishibashi; M Nakazawa; S Imai
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

2.  R56865 is antifibrillatory in reperfused ischemic guinea-pig hearts, even when given only during reperfusion.

Authors:  E Scheufler; A Mozes; I Guttmann; B Wilffert
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.